Amgen Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.7% | +8.5% | +3.0% | -16.9% | -10.1% | +5.4% | -2.8% | +6.5% | +49.2% | -5.5% | -1.4% | |
| – | +11.0% | +19.5% | +7.5% | -24.0% | -51.0% | +14.7% | -8.3% | +14.4% | +36.7% | -4.3% | +0.1% | |
| – | +11.1% | -21.8% | +17.2% | +82.8% | -13.1% | +3.8% | +27.5% | -4.5% | +43.5% | +9.4% | -23.8% | |
| – | +16.1% | +21.4% | +9.4% | -29.7% | -69.6% | +19.5% | -24.5% | +15.8% | +17.6% | +9.4% | -23.8% | |
| – | +17.6% | +5.7% | +2.3% | +10.6% | +13.3% | +11.5% | +29.0% | +9.5% | +24.2% | -5.6% | +27.6% | |
| – | -8.0% | +12.7% | +3.2% | +3.7% | +21.9% | +8.6% | +5.0% | +20.7% | +93.1% | -26.5% | -11.0% | |
| – | -6.1% | +1.1% | +0.6% | -0.6% | -0.6% | -0.8% | +6.0% | +4.7% | – | – | – | |
| – | 0.0% | -0.2% | +0.1% | -0.4% | +0.0% | -0.1% | +1.4% | +4.3% | +20.0% | +0.0% | +0.2% | |
| – | -8.3% | -11.7% | -16.2% | -13.5% | +160.8% | -14.6% | -8.5% | +5.9% | +103.0% | -15.1% | -19.6% | |
| – | +0.3% | +10.1% | +14.6% | -1.5% | -7.2% | +7.0% | +1.7% | +12.8% | +47.9% | -5.5% | -4.7% | |
| – | +23.6% | +29.3% | -19.5% | +49.5% | -4.8% | -9.2% | +4.6% | +28.8% | +17.2% | +25.6% | +10.3% | |
| – | +349.4% | +96.0% | -73.8% | +283.6% | -33.2% | -96.9% | -4.4% | +1,728.7% | -9.3% | +146.0% | +29.5% | |
| – | -3.0% | -5.0% | +47.4% | -10.7% | +13.6% | +3.6% | -3.9% | +15.1% | +1.1% | +20.0% | +24.1% | |
| – | -3.0% | +3.0% | +13.2% | -13.7% | -8.7% | +22.1% | +1.0% | +12.4% | +69.1% | -10.5% | -11.6% | |
| – | +8.9% | +6.4% | -15.5% | -50.5% | -22.6% | -2.7% | -28.8% | -45.4% | +70.2% | -5.7% | +47.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.5% | -1.6% | -2.5% | -9.5% | -8.4% | -3.1% | -2.9% | -5.6% | -0.6% | +0.6% | +0.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.